GlassScriptPhysician profile
Joshua W Keyes
NPI 1447252028
$698.57
in general payments reported to CMS, 2019-2025
13 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $53.09 · 2021: $56.13 · 2022: $67.00 · 2023: $116 · 2024: $17.57 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $274.77 | 2019-2025 | Smart Toe, Variax, Augment Injectable |
| Trilliant Surgical LLC. | $160.49 | 2021-2025 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, 13mm Star E+ Sliding Core Star Total Ankle |
| Orthofix Medical, INC. | $54.00 | 2022-2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $38.90 | 2020-2021 | |
| Tactile Systems Technology INC | $27.16 | 2019-2025 | Nimbl, Flexitouch Plus |
| Melinta Therapeutics, LLC | $25.76 | 2019 | |
| Medshape, INC. | $20.94 | 2022 | |
| Organogenesis INC. | $17.60 | 2019 | |
| Medtronic, INC. | $17.57 | 2024 | Venaseal |
| Curonix LLC | $17.15 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Wright Medical Technology, INC. | $14.86 | 2019 | |
| Kci USA, INC. | $14.72 | 2020 | |
| Averitas Pharma INC. | $14.65 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Keyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.